Chimeric antigen receptor T-cell therapy has exhibited “compelling” efficacy and safety in lupus, allowing 84% of patients to ...

C HICAGO -- People who died with systemic lupus erythematosus (SLE) were far more likely than car crash victims to have ...

Common recommendations are to start HCQ treatment with doses of 200 mg or 400 mg per day. Some formulas suggest a ...

Phase I/II data for rese-cel point to its therapeutic potential in systemic lupus erythematosus and lupus nephritis, as well ...

Deucravacitinib reduces circulating proteins associated with kidney dysfunction in patients with systemic lupus erythematosus, according to data presented at ACR Convergence 2025.“Specific plasma ...

Phase III data for dapirolizumab pegol presented at the 2025 conference of the American College of Rheumatology showed ...

While mycophenolate mofetil is standard of care treatment for lupus nephritis, belimumab might be an alternative.

Recognizing the early signs of lupus is crucial for timely intervention. The following are some common symptoms associated with the disease: Fatigue and malaise: Many patients report a persistent ...

Lupus is notorious for its unpredictable symptoms, which can vary significantly from person to person. Some of the most common symptoms include: Fatigue: A feeling of overwhelming tiredness that does ...

Phase 3 study presentations in SLE to show efficacy results across multiple clinical endpoints, including low disease ...

The Lupus Foundation of America (LFA) proudly presented eight abstracts and sessions during the 2025 American College of Rheumatology (ACR) Convergence with the goal of advancing science, improving ...

Lupus continues to carry a heavy burden despite advances in immunosuppressive therapy warranting complementary care approaches.